Manufacturer record
Modern Laboratories: regulatory record
Last checked 20 September 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
24 batches manufactured by Modern Laboratories (Madhya Pradesh) were declared Not of Standard Quality between February 2020 and July 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Records by type
24 records linked to Modern Laboratories in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Amoxycillin Oral Suspension IP | AMS2532Mfg 2025-06 · Exp 2026-11 | Content of Amoxycillin.Other | FDL, VadodaraState lab | Jul 2026 |
| Ondansetron Hydrochloride Oral Solution IP | ODS3602Mfg 2026-01 · Exp 2027-12 | pH and AssayAssay | SDTL, TripuraState lab | Mar 2026 |
| Meropenem Injection I.P. 125 mg | MPI2508Mfg 2025-08 · Exp 2027-07 | The sample does not conform to I.P. with respect to test for Clarity of solution, Particulate matter and Description.Description | CDL, KolkataCDSCO lab | Jan 2026 |
| Meropenem Injection I.P. 125 mg | MPI2504Mfg 2025-05 · Exp 2027-04 | The sample does not conform to I.P. with respect to test for Particulate matter, Clarity of solution, Assay of Meropenem calculated as Anhydrous Meropenem and Description.Assay | CDL, KolkataCDSCO lab | Jan 2026 |
| Meropenem Injection I.P. 125 mg | MPI2506Mfg 2025-07 · Exp 2027-06 | The sample does not conform to I.P. with respect to test for Particulate matter, Clarity of solution and Assay of Meropenem calculated as Anhydrous MeropenemAssay | CDL, KolkataCDSCO lab | Jan 2026 |
| Folic Acid and Ferrous Sulphate Tablets (Large) N.F.I. | FFT3502Mfg 2025-08 · Exp 2027-07 | The sample does not conform to Standard Quality in respect of the test for Disintegration performedDisintegration | SDTL Govt. of Tripura, AgartalaState lab | Jan 2026 |
| Folic Acid and Ferrous Sulphate Tablets (Large) N.F.I. | FFT3501Mfg 2025-06 · Exp 2027-05 | The sample does not conform to Standard Quality in respect of the test for Disintegration performedDisintegration | SDTL Govt. of Tripura, AgartalaState lab | Jan 2026 |
| Telmisartan Tablets IP 80 mg | TST 4510Mfg 2025-08 · Exp 2027-07 | The sample does not conform to standard quality in respect of the tests for "Description" performed.Description | State Drugs Testing Laboratory, Govt. of Tripura, Agartala. State- TripuraState lab | Nov 2025 |
| Meropenam Injection IP 500 mg | PMI3519Mfg 2025-06 · Exp 2027-05 | bacterial EndotoxinsBacterial endotoxins | Food & Drugs Laboratory, VadodaraState lab | Nov 2025 |
| Ibuprofen Tablets I.P. 400 mg | INT 3504Mfg 2025-08 · Exp 2027-07 | The sample does not conform to standard quality in respect of the tests for "Description" performed.Description | State Drugs Testing Laboratory, Govt. of Tripura, Agartala. State- TripuraState lab | Nov 2025 |
| Ibuprofen Tablets I.P. 400 mg | INT 3505Mfg 2025-08 · Exp 2027-07 | The sample does not conform to standard quality in respect of the tests for "Description" performed.Description | State Drugs Testing Laboratory, Govt. of Tripura, Agartala. State- TripuraState lab | Nov 2025 |
| Vitamin B m plex Tablets N.F.I | VBT2442Mfg 2024-04 · Exp 2026-03 | DescriptionDescription | SDTL Agartala, TripuraState lab | Oct 2024 |
| Vitamin B Complex Tablets N.F.I | VBT2498Mfg 2024-06 · Exp 2026-05 | DescriptionDescription | SDTL Agartala, TripuraState lab | Oct 2024 |
| Itraconazole Capsules USP 100 mg | IZC2401Mfg 2024-04 · Exp 2026-03 | DissolutionDissolution | SDTL Agartala, TripuraState lab | Oct 2024 |
| Itraconazole Capsules USP 100 mg | IZC2401Mfg 2024-04 · Exp 2026-03 | DissolutionDissolution | SDTL Agartala, TripuraState lab | Oct 2024 |
| Diclofenac Sodium, Paracetamol & Chlorzoxazone Tablets | DCPT3310Mfg 2023-09 · Exp 2025-08 | DisintegrationDisintegration | CDL KolkataCDSCO lab | Oct 2024 |
| Amoxycillin and Potassium Clavulanate Tablets IP 375 mg | APCT2305Mfg 2023-02 · Exp 2025-01 | Assay of Amoxycillin, Clavulanic Acid & Dissolution of Amoxycillin, Clavulanic AcidAssay | CDL KolkataCDSCO lab | Jan 2024 |
| FRUSEMIDE INJECTION IP 10MG/ML. (FRUSEMIDE) | FEI2208Mfg 2022-09 · Exp 2024-08 | Sterility & Bacterial EndotoxinsSterility | RDTL GuwahatiState lab | Nov 2023 |
| Doxycycline Hydrochloride Capsules IP 100 mg | 115387Mfg 2022-10 · Exp 2024-09 | AssayAssay | CDL KolkataCDSCO lab | May 2023 |
| Calcium and Vitamin D3 Tablets I.P. | MGCT2020Mfg 2020-12 · Exp 2022-11 | Identification and Assay of Vitamin D3Assay | RDTL GuwahatiState lab | Nov 2022 |
| Cloxacillin Capsules I.P. 250 mg | CNC2001Mfg 2020-03 · Exp 2022-02 | Dissolution & AssayAssay | CDL KolkataCDSCO lab | Mar 2022 |
| Erythromycin Stearate Tablets I.P. 250 mg | ENT1911Mfg 2019-12 · Exp 2021-11 | Description & DissolutionDissolution | CDL KolkataCDSCO lab | Nov 2020 |
| Amikacin Sulphate Injection I.P. 500mg / 2ml | ANI3905Mfg 2019-06 · Exp 2021-05 | Description and Particulate MatterDescription | CDL KolkataCDSCO lab | Mar 2020 |
| Ondansetron Injection I.P. 2 mg/ml, 2 ml | ONI1923Mfg 2019-06 · Exp 2021-05 | Description and Particulate MatterDescription | CDL KolkataCDSCO lab | Feb 2020 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.